Arif Bilal
Insider CIK 1959750 · KALV Chief Operations Officer · SRPT Chief Tech Ops Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 49,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 100,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2026-01-16 | 2026-01-21 | 49,000 | — | $0 | 49,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2025-10-08 | 2025-10-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2025-08-05 | 2025-08-06 | 6,250 | — | $0 | 6,250 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2025-03-10 | 2025-03-11 | 16,644 | — | $0 | 16,644 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2025-03-10 | 2025-03-11 | 523 | $100.13 | $52.4K | 24,224 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2025-03-10 | 2025-03-11 | 8,276 | — | $0 | 32,500 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2025-03-07 | 2025-03-10 | 8,527 | $103.70 | $884.2K | 24,747 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2025-03-07 | 2025-03-10 | 508 | $103.70 | $52.7K | 33,274 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2025-03-06 | 2025-03-10 | 17,500 | — | $0 | 0 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2025-03-06 | 2025-03-10 | 17,500 | — | $0 | 33,782 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2025-03-04 | 2025-03-06 | 233 | $101.34 | $23.6K | 16,282 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2025-03-04 | 2025-03-06 | 281 | $101.34 | $28.5K | 16,515 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2025-03-03 | 2025-03-04 | 719 | $103.77 | $74.6K | 16,796 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2025-02-11 | 2025-02-13 | 3,500 | — | $0 | 17,500 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2024-06-25 | 2024-06-25 | 3,898 | $163.23 | $636.3K | 17,363 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2024-06-24 | 2024-06-25 | 300 | $164.61 | $49.4K | 22,185 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2024-06-24 | 2024-06-25 | 2,352 | $164.64 | $387.2K | 29,120 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2024-06-24 | 2024-06-25 | 224 | $167.13 | $37.4K | 21,261 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2024-06-24 | 2024-06-25 | 700 | $166.10 | $116.3K | 21,485 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2024-06-24 | 2024-06-25 | 1,055 | $163.83 | $172.8K | 22,485 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2024-06-24 | 2024-06-25 | 5,580 | $162.31 | $905.7K | 23,540 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2024-06-21 | 2024-06-25 | 6,250 | — | $0 | 0 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2024-06-21 | 2024-06-25 | 6,250 | — | $0 | 6,250 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2024-06-21 | 2024-06-25 | 6,250 | — | $0 | 31,472 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2024-03-08 | 2024-03-11 | 472 | $123.14 | $58.1K | 25,222 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2024-03-07 | 2024-03-11 | 506 | $120.49 | $61.0K | 25,694 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2024-03-04 | 2024-03-06 | 237 | $125.32 | $29.7K | 26,200 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2024-03-04 | 2024-03-06 | 285 | $125.32 | $35.7K | 26,437 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-03-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2024-03-01 | 2024-03-05 | 251 | $126.19 | $31.7K | 22,836 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2024-03-01 | 2024-03-05 | 6,000 | — | $0 | 28,836 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2024-03-01 | 2024-03-05 | 1,543 | $128.58 | $198.4K | 27,293 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2024-03-01 | 2024-03-05 | 457 | $129.71 | $59.3K | 26,836 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2024-03-01 | 2024-03-05 | 114 | $126.19 | $14.4K | 26,722 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2023-12-01 | 2023-12-05 | 3,682 | $80.34 | $295.8K | 22,886 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2023-03-30 | 2023-04-04 | 307 | $136.66 | $42.0K | 26,367 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2023-03-08 | 2023-03-10 | 314 | $153.19 | $48.1K | 26,674 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2023-03-06 | 2023-03-08 | 27,000 | — | $0 | 27,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2023-03-06 | 2023-03-08 | 4,500 | — | $0 | 26,988 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2023-03-06 | 2023-03-08 | 154 | $157.21 | $24.2K | 22,488 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2023-03-06 | 2023-03-08 | 186 | $157.21 | $29.2K | 22,642 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2023-03-01 | 2023-03-03 | 80 | $147.57 | $11.8K | 22,837 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2023-03-01 | 2023-03-03 | 172 | $147.57 | $25.4K | 22,828 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2022-12-31 | 2023-01-04 | 30,000 | — | $0 | 30,000 | SEC↗ |